J&J’s Mesquita predicts market shift
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
“The OTC market of the future may not necessarily be the OTC of the past,” predicted Johnson & Johnson (J&J) Consumer head, Jorge Mesquita, at the Barclays Global Consumer Staples Conference.
You may also be interested in...
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.